ADVFN US – Market Content Editor

Macy’s Inc (NYSE:M) has revised downward its full-year 2025 earnings and adjusted EBITDA margin guidance, citing the effects of tariffs, softer consumer discretionary spending, and intensified promotional competition. Nevertheless, the company’s first-quarter results surpassed analyst expectations. Following the report, Macy’s shares rose over 1% in premarket trading as of 11:07 GMT. The department store now…

Dick’s Sporting Goods (NYSE:DKS) delivered first-quarter results that exceeded expectations, driven by record sales and continued momentum in comparable store performance. Despite the strong report, shares dipped 0.6% following the announcement. For the quarter ending May 3, 2025, the retailer reported adjusted earnings per share of $3.37, surpassing analysts’ projections of $3.20. Revenue reached $3.17…

Brooge Energy Limited (NASDAQ:BROG) saw its stock soar by 70% after announcing a conditional agreement to sell its subsidiaries, BPGIC FZE and BPGIC Phase III FZE, to Gulf Navigation Holding PJSC (GulfNav). This strategic move is expected to significantly reshape Brooge’s business trajectory. Valued at roughly $884 million, the transaction includes around $125.3 million in…

Spero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock soar by 240% after announcing highly encouraging results from its Phase 3 PIVOT-PO trial, conducted in collaboration with development partner GSK plc (LSE/NYSE: GSK). The trial assessed tebipenem HBr, an investigational oral carbapenem antibiotic aimed at treating complicated urinary tract infections (cUTIs). The study, which enrolled 1,690 patients,…

Abercrombie & Fitch Co. (NYSE:ANF) shares surged 25% in premarket trading Wednesday after reporting first-quarter results that exceeded earnings expectations, despite a slight revenue shortfall. The retailer posted adjusted earnings per share of $1.59, topping the $1.33 consensus by $0.26. Revenue reached $1.06 billion – just under the $1.08 billion forecast – but still marked…

Boston Scientific (NYSE:BSX) shares fell 4% after the company announced it will discontinue global sales of its ACURATE neo2 and ACURATE Prime Aortic Valve Systems. The decision follows discussions with regulatory agencies that resulted in stricter clinical and compliance requirements. On May 28, 2025, the company said the heightened regulatory demands would require resources and…

Monro, Inc. (NASDAQ:MNRO) saw its stock surge 8.85% in premarket trading Wednesday after the company topped revenue expectations for its fiscal fourth quarter, even as it reported a deeper loss than anticipated. The auto service and tire company posted $295 million in revenue for the quarter ending March 29, 2025, exceeding analysts’ projection of $288.58…

Edwards Lifesciences (NYSE:EW) saw its shares rise by 3% following news that competitor Boston Scientific (NYSE:BSX) is exiting the aortic valve market. Boston Scientific announced it will cease global distribution of its ACURATE neo2 and ACURATE Prime Aortic Valve Systems and abandon its efforts to secure U.S. FDA approval. The company attributed the decision to…

Mobileye Global (NASDAQ:MBLY) saw its shares jump over 5% in premarket trading Wednesday following news of a significant contract award from a prominent global car manufacturer. The company will supply its advanced imaging radar system for the automaker’s future line of autonomous vehicles. The radar will play a central role in a hands-free, eyes-off driving…

U.S. stock futures edged lower on Wednesday ahead of a highly anticipated earnings report from Nvidia, the semiconductor powerhouse that has been a key player benefiting from the surge in AI-related demand. Meanwhile, Stellantis announced a new CEO appointment, and a weak Japanese government bond auction sparked concerns about demand for long-term debt. Nvidia’s Earnings…